Product Description
Darba 25 Injection is used in the treatment of anemia that may have occurred due to chronic kidney disease or chemotherapy. It works by stimulating the bone marrow to produce more red blood cells.Darba 25 Injection is a medicine that needs to be used with utmost care because it can lead to serious side effects. It is important that you seek treatment from a doctor who is experienced in providing this medical therapy. You should follow all the directions of the doctor strictly. It is given under the supervision of a healthcare professional.
Common side effects include abdominal pain, high blood pressure, rash, injection site pain, breathlessness, cough, and peripheral edema. Inform your doctor if there are symptoms of very high blood pressure, such as severe headache, problems with your eyesight, nausea, vomiting, or fits (seizures).
Precise Anemia Treatment for Diverse NeedsDarbesa 25 Mg Injection, formulated with Darbepoetin Alfa, targets anemia resulting from chronic kidney disease or chemotherapy. Its biotechnological composition offers a reliable solution for both adults and children as prescribed, ensuring patients receive effective support for improved red blood cell production. This specialty injection is designed for controlled administration in clinical or hospital settings under medical supervision.
Safe Handling and StorageProper storage is crucial for Darbesa Injection. Keep the pre-filled syringe refrigerated between 2C and 8C. Protect it from light, do not shake, and never freeze the solution. These handling instructions help preserve the medicine's effectiveness, ensuring safety and optimal performance throughout its 24-month shelf life.
FAQ's of Darbesa 25 Mg Injection:
Q: How should Darbesa 25 Mg Injection be administered?
A: Darbesa 25 Mg Injection is given either subcutaneously or intravenously, strictly by or under the guidance of healthcare professionals in hospitals or clinics. Self-administration is not recommended.
Q: What is the main benefit of using Darbesa Injection?
A: The injection stimulates red blood cell production, helping manage anemia caused by chronic kidney disease or chemotherapy, thereby improving overall quality of life for patients.
Q: Who can use Darbesa 25 Mg Injection?
A: Darbesa can be prescribed to both adults and pediatric patients diagnosed with anemia associated with renal insufficiency or chemotherapy, as determined by a physician.
Q: When is Darbesa typically prescribed?
A: This injection is used when patients develop anemia due to chronic renal failure or are undergoing chemotherapy, which diminishes red blood cell counts.
Q: What precautions should be taken during storage and handling?
A: Darbesa must be refrigerated at 2C-8C, protected from light, and must not be frozen or shaken. These precautions maintain the integrity and effectiveness of the medicine.
Q: How is the dosage for Darbesa Injection determined?
A: The appropriate dosage is individualized and prescribed by a physician based on patient age, condition, and hemoglobin levels. Patients should not alter the dosage themselves.